Top Industry Leaders in the Breast Biopsy Market
Latest Breast Biopsy Companies Updates
Hologic,Introduced their new Symphony® Guided Biopsy System featuring enhanced imaging capabilities and improved needle placement accuracy.Collaborated with leading researchers on clinical trials evaluating the efficacy of their VABio™ Breast Biopsy System for detecting breast cancer.
Boston Scientific Corporation Received FDA approval for their Eclipse™ Tissue Sampling System, a novel minimally invasive needle biopsy device for breast cancer diagnosis.Partnered with healthcare providers to implement advanced biopsy technologies and optimize workflow efficiency in breast cancer diagnosis.
Cantel Medical Corporation Launched their TruCore® PRO Biopsy System with innovative targeting technology and needle design for improved lesion access and sample acquisition.Focused on expanding their global presence and market share in the breast biopsy market.
Exact Sciences Corporation Announced positive results from Phase 3 clinical trials demonstrating the effectiveness of their Oncotype DX Recurrence Score® test in guiding treatment decisions for early-stage breast cancer patients after core needle biopsy.Partnered with laboratories and medical centers to increase access to their personalized molecular diagnostics for breast cancer risk assessment.
List of Breast Biopsy Key companies in the market
-
Medical Technologies LLC,
-
STERYLAB S.r.l.,
-
ARGON MEDICAL,
-
Danaher,
-
Cianna Medical,
-
United Medical Systems Inc.,
-
Stryker,
-
Hologic Inc.,
-
Devicor Medical Products Inc.,
-
F. Hoffmann-La Roche Ltd.,
-
OncoCyte Corporation